Status:
TERMINATED
Walking Capacity in Parkinson's Disease (PD-Walk)
Lead Sponsor:
Natalie Allen
Collaborating Sponsors:
South West Sydney Local Health District
Conditions:
Idiopathic Parkinson's Disease
Eligibility:
All Genders
30-80 years
Phase:
NA
Brief Summary
The major aim of this study is to determine the efficacy of a home-based treadmill walking program in improving walking capacity and quality of life in people with early mid-stage Parkinson's disease(...
Detailed Description
After Alzheimer's disease, Parkinson's disease (PD) is the most common degenerative neurological condition suffered by Australians, with more than 30,000 Australians having PD at any one time (Parkins...
Eligibility Criteria
Inclusion
- clinical diagnosis of idiopathic Parkinson's disease
- aged 30-80 years old
- subjective disturbance of gait and / or Unified Parkinson's disease rating scale (UPDRS) gait subscore of 1
- sedentary, defined as performing less than 2 hours / week of leisure-time physical activity over the prior 3 months
- have adapted to their current anti-Parkinsonian medication for at least 2 weeks
Exclusion
- motor fluctuations or dyskinesias which are disabling
- require the use of a walking aid
- more than one fall in the last 12 months
- Mini-Mental State Examination score of \<24
- exhibit other neurological or musculoskeletal conditions affecting walking
- chest pain at rest or during exercise in the last 3 months, or heart attack, angioplasty or heart surgery in the last 6 months
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00261781
Start Date
May 1 2005
End Date
September 1 2012
Last Update
May 29 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Westmead Hospital
Sydney, New South Wales, Australia, 2145